1. Recipient treatment with L-arginine attenuates donor lung injury associated with hemorrhagic shock.
- Author
-
Preissler G, Löhe F, Ebersberger U, Huff I, Bittmann I, Messmer K, Jauch KW, and Angele MK
- Subjects
- Animals, Arginine administration & dosage, Blood Pressure, Carotid Artery, External, Catheterization, Central Venous, Humans, Infusions, Intravenous, Lung Transplantation adverse effects, Lung Transplantation physiology, Models, Animal, Organ Preservation methods, Reperfusion Injury prevention & control, Resuscitation adverse effects, Resuscitation methods, Swine, Thoracotomy, Tissue Donors, Arginine therapeutic use, Lung Transplantation pathology, Shock, Hemorrhagic prevention & control
- Abstract
Background: Organ donors are frequently trauma victims, but the impact of donor hemorrhagic shock and resuscitation (HSR) on pulmonary graft function has not been assessed. L-arginine treatment during reperfusion increases the production of endothelial nitric oxide and thus ameliorates ischemia-reperfusion injury. Objective of the present porcine study was to investigate the effect of donor hemorrhage on pulmonary graft function and potential beneficial effects of L-arginine administration., Methods: In the control-group (n=6), lungs were harvested from donors without hypotensive periods. In the HSR-group (n=6) and HSR-Arg-group (n=6), donors were subjected to hemorrhagic shock (40% blood shed) and resuscitation before harvest. Left lungs were transplanted after hypothermic preservation of 18 hr, and graft function was observed for 6 hr after reperfusion. Recipients in the HSR-Arg-group received a bolus of L-arginine (50 mg/kg BW) intravenously 5 min before reperfusion followed by a continuous intravenous administration of L-arginine 200 mg/kg BW for 2 hr. Tissue specimens and bronchoalveolar lavage fluid were obtained at the end of the observation period., Results: Donor lung function did not differ between study groups. Compared with the control group, pulmonary graft gas exchange was significantly impaired in the HSR-group. Graft function in the HSR-Arg-group did not differ from control organs. Neutrophil fraction, protein content, and malondialdehyde levels in the bronchoalveolar lavage fluid in the HSR-group were higher compared with control and HSR-Arg-Group., Conclusion: Although fulfilling ideal donor criteria, pulmonary graft function of lungs harvested from donors subjected to HSR is impaired, but improves significantly when l-arginine is administered during reperfusion.
- Published
- 2009
- Full Text
- View/download PDF